文献速递前列腺癌

前列腺特异性膜抗原正电子发射断层扫描与常规影像对中高危前列腺癌初始分期的诊断准确性头对头比较:系统综述与Meta分析

Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis.
PubMed 文献 · Eur Urol · 2023-04-07

该系统综述与Meta分析纳入31项研究共2431例患者,头对头比较PSMA-PET与常规影像(mpMRI、CT、骨扫描)对中高危前列腺癌初始分期的诊断准确性。结果显示PSMA-PET在检测前列腺外侵犯、精囊侵犯、淋巴结转移和骨转移方面均较常规影像更敏感和/或更特异。作者结论认为PSMA-PET显著优于常规影像,建议将其作为前列腺癌初始分期的一线方法。

要点

  • PSMA-PET/MRI检测前列腺外侵犯的敏感性为78.7%,高于mpMRI的52.9%。
  • 淋巴结分期中PSMA-PET敏感性73.7%、特异性97.5%,均高于mpMRI的38.9%和82.6%。
  • 骨转移分期中PSMA-PET敏感性98.0%、特异性96.2%,均高于骨扫描的73.0%和79.1%。

核心结论

  • 直接比较显示PSMA-PET显著优于常规影像,提示PSMA-PET应作为前列腺癌初始分期的一线方法。

研究设计与样本

  • 系统综述与Meta分析,检索PubMed、EMBASE、CENTRAL和Scopus数据库自建库至2021年12月。
  • 仅纳入患者同时接受PSMA-PET和常规影像检查、且影像结果以组织病理学或复合参考标准为参照的研究。
  • 共纳入31项研究,2431例患者。
  • 使用QUADAS-2清单及其比较综述扩展版QUADAS-C评估质量。
  • 将影像模态作为协变量加入双变量混合效应Meta回归模型进行配对比较,采用似然比检验判断差异是否具有统计学显著性。

主要发现

  • 检测前列腺外侵犯时,PSMA-PET/MRI敏感性78.7%,mpMRI敏感性52.9%。
  • 检测精囊侵犯时,PSMA-PET/MRI敏感性66.7%,mpMRI敏感性51.0%。
  • 淋巴结分期中,PSMA-PET敏感性73.7%、特异性97.5%,mpMRI敏感性38.9%、特异性82.6%。
  • 淋巴结分期中,PSMA-PET敏感性73.2%、特异性97.8%,CT敏感性38.5%、特异性83.6%。
  • 骨转移分期中,PSMA-PET敏感性98.0%、特异性96.2%,骨扫描(伴或不伴SPECT)敏感性73.0%、特异性79.1%。

关键数值与推荐

  • PSMA-PET/MRI检测前列腺外侵犯的敏感性为78.7%,mpMRI为52.9%。
  • PSMA-PET/MRI检测精囊侵犯的敏感性为66.7%,mpMRI为51.0%。
  • 淋巴结分期中PSMA-PET敏感性73.7%、特异性97.5%,mpMRI敏感性38.9%、特异性82.6%。
  • 淋巴结分期中PSMA-PET敏感性73.2%、特异性97.8%,CT敏感性38.5%、特异性83.6%。
  • 骨转移分期中PSMA-PET敏感性98.0%、特异性96.2%,骨扫描(伴或不伴SPECT)敏感性73.0%、特异性79.1%。

临床怎么用

  • 作者结论认为PSMA-PET应作为前列腺癌初始分期的一线方法。

局限性

  • 影像模态间时间间隔超过1个月被识别为所有淋巴结分期分析中异质性的来源。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Whether prostate-specific membrane antigen positron emission tomography (PSMA-PET) should replace conventional imaging modalities (CIM) for initial staging of intermediate-high risk prostate cancer (PCa) requires definitive evidence on their relative diagnostic abilities. OBJECTIVE: To perform head-to-head comparisons of PSMA-PET and CIM including multiparametric magnetic resonance imaging (mpMRI), computed tomography (CT) and bone scan (BS) for upfront staging of tumour, nodal, and bone metastasis. EVIDENCE ACQUISITION: A search of the PubMed, EMBASE, CENTRAL, and Scopus databases was conducted from inception to December 2021. Only studies in which patients underwent both PSMA-PET and CIM and imaging was referenced against histopathology or composite reference standards were included. Quality was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 (QUADAS-2) checklist and its extension for comparative reviews (QUADAS-C). Pairwise comparisons of the sensitivity and specificity of PSMA-PET versus CIM were performed by adding imaging modality as a covariate to bivariate mixed-effects meta-regression models. The likelihood ratio test was applied to determine whether statistically significant differences existed. EVIDENCE SYNTHESIS: A total of 31 studies (2431 patients) were included. PSMA-PET/MRI was more sensitive than mpMRI for detection of extra-prostatic extension (78.7% versus 52.9%) and seminal vesicle invasion (66.7% versus 51.0%). For nodal staging, PSMA-PET was more sensitive and specific than mpMRI (73.7% versus 38.9%, 97.5% versus 82.6%) and CT (73.2% versus 38.5%, 97.8% versus 83.6%). For bone metastasis staging, PSMA-PET was more sensitive and specific than BS with or without single-photon emission computerised tomography (98.0% versus 73.0%, 96.2% versus 79.1%). A time interval between imaging modalities >1 month was identified as a source of heterogeneity across all nodal staging analyses. CONCLUSIONS: Direct comparisons revealed that PSMA-PET significantly outperforms CIM, which suggests that PSMA-PET should be used as a first-line approach for the initial staging of PCa. PATIENT SUMMARY: We reviewed direct comparisons of the ability of a scan method called PSMA-PET (prostate-specific membrane antigen positron emission tomography) and current imaging methods to detect the spread of prostate cancer outside the prostate gland. We found that PSMA-PET is more accurate for detection of the spread of prostate cancer to adjacent tissue, nearby lymph nodes, and bones.

来源:Eur Urol,查看原文。版权归原作者所有。

引用

  1. Chow KM, So WZ, Lee HJ, et al. Head-to-head Comparison of the Diagnostic Accuracy of Prostate-specific Membrane Antigen Positron Emission Tomography and Conventional Imaging Modalities for Initial Staging of Intermediate- to High-risk Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol. 2023. PMID: 37032189. doi:10.1016/j.eururo.2023.03.001

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。